InvestVerdict
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · Growth · Index Funds · Scheme code 150930
Fund houseICICI Prudential Mutual Fund
CategoryIndex Funds
Plan & optionDirect · Growth
History3.7 years
Returns (%)
| 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y | Launch | |
|---|---|---|---|---|---|---|---|---|---|
| This scheme | 2.35 | 11.09 | 17.68 | 23.89 | 21.23 | — | — | — | 22.23 |
| Nifty 100 benchmark |
0.25 | 3.49 | -1.52 | 1.84 | 10.52 | 9.38 | — | — | 12.79 |
| Index Funds category median |
— | — | — | 5.83 | 8.03 | 9.81 | — | 11.77 | — |
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.
Risk
| Volatility | Sharpe | Sortino | Beta | Alpha | Max fall | R² | |
|---|---|---|---|---|---|---|---|
| This scheme | 14.3% | 1.03 | 1.55 | 0.72 | 14.56% | -16.6% | 38.45 |
| Nifty 100 benchmark |
17.1% | 0.23 | 0.32 | — | — | -37.0% | — |
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 44 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
| Windows | Worst | Median | Best | Periods that lost money |
|---|---|---|---|---|
| 133 | -5.5% | 15.1% | 59.9% | 11% |
Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.